By-health Co Ltd
SZSE:300146

Watchlist Manager
By-health Co Ltd Logo
By-health Co Ltd
SZSE:300146
Watchlist
Price: 12.4 CNY -4.1% Market Closed
Market Cap: 21.1B CNY
Have any thoughts about
By-health Co Ltd?
Write Note

By-health Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

By-health Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
By-health Co Ltd
SZSE:300146
Cost of Revenue
-ÂĄ2.9B
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cost of Revenue
-ÂĄ15.2B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Cost of Revenue
-ÂĄ2.1B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Cost of Revenue
-ÂĄ3.3B
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Cost of Revenue
-ÂĄ1.5B
CAGR 3-Years
-31%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cost of Revenue
-ÂĄ577m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

By-health Co Ltd
Glance View

Market Cap
21.1B CNY
Industry
Consumer products

By-health Co., Ltd. engages in the research, development, production, and sales of vitamin and dietary supplements. The company is headquartered in Guangzhou, Guangdong and currently employs 3,888 full-time employees. The company went IPO on 2010-12-15. The firm's main products include protein powders, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets, grape seed tablets, wheat germ oil soft capsules, deep-sea fish oil soft capsules, tuna oil soft capsules, propolis soft capsules, soybean phospholipids soft capsules and squalene soft capsules, among others. The firm distributes its products primarily in domestic market.

Intrinsic Value
17.42 CNY
Undervaluation 29%
Intrinsic Value
Price

See Also

What is By-health Co Ltd's Cost of Revenue?
Cost of Revenue
-2.9B CNY

Based on the financial report for Dec 31, 2023, By-health Co Ltd's Cost of Revenue amounts to -2.9B CNY.

What is By-health Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-16%

Over the last year, the Cost of Revenue growth was -17%. The average annual Cost of Revenue growth rates for By-health Co Ltd have been -9% over the past three years , -16% over the past five years .

Back to Top